Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Erdeve, Ö; Okulu, E; Singh, Y; Sindelar, R; Oncel, MY; Terrin, G; Boscarino, G; Bülbül, A; Sallmon, H; Atasay, B; Ovalı, F; Clyman, RI.
An Update on Patent Ductus Arteriosus and What is Coming Next.
Turk Arch Pediatr. 2022; 57(2):118-131
Doi: 10.5152/TurkArchPediatr.2022.21361
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Sallmon Hannes
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Patent ductus arteriosus is the most common cardiovascular condition in preterm infants. There is a significant uncertainty about when and how to close ductus arteriosus in preterm infants due to a high spontaneous closure rate even in very immature preterm infants. Diagnosis and management of patent ductus arteriosus remain a challenge for both neonatologists and pediatric cardiologists. Researchers have tried to define a balance between an expectant approach and active treatment in selected infants. This review aimed to focus on the pathophysiology and management of patent ductus arteriosus and to make suggestions about approaches that might eliminate the association of morbidities with patent ductus arteriosus.
- Find related publications in this database (Keywords)
- patent ductus arteriosus
- preterm
- conservative
- medical
- surgical
- treatment